Master Supreme Court limits private Rule 10b-5 liability by holding that investors cannot sue secondary actors whose undisclosed conduct was not relied upon by the market. with this comprehensive case brief.
Stoneridge is a cornerstone Supreme Court decision defining the outer boundary of private liability under Section 10(b) of the Securities Exchange Act of 1934 and SEC Rule 10b-5. The case answers whether so-called "secondary actors"—customers, suppliers, bankers, and other business partners of an issuer—can be held liable in a private securities fraud action for participating in a deceptive scheme that enables the issuer to misstate its financials. The Court's answer was no where the secondary actors' conduct is not itself communicated to the market and investors did not rely on that conduct.
By conditioning private Rule 10b-5 liability on investor reliance that is traceable to the defendant's own public statements or conduct attributed to that defendant, Stoneridge fortified Central Bank's prohibition on private aiding-and-abetting claims and curtailed expansive "scheme liability" theories. The decision reflects the Court's broader concern with the judicially implied nature of the 10b-5 private right of action, potential for overbroad and unpredictable liability for peripheral actors, and deference to Congress's design—including the PSLRA—allocating aiding-and-abetting enforcement authority to the SEC rather than private plaintiffs.
Stoneridge Investment Partners, LLC v. Scientific-Atlanta, Inc., 552 U.S. 148 (2008) (Supreme Court of the United States)
Charter Communications, a cable television company, sought to meet analysts' cash-flow targets. To do so, its executives arranged with two of Charter's set-top box suppliers, Scientific-Atlanta, Inc. and Motorola, Inc., to increase the price Charter paid for set-top boxes while the suppliers simultaneously agreed to purchase advertising from Charter in offsetting amounts. Although the transactions were economically neutral for the suppliers, Charter recorded the advertising revenue as operating revenue and capitalized the higher equipment costs, thereby inflating reported operating cash flow. The suppliers documented the transactions as ordinary business deals and had no role in drafting, creating, or disseminating Charter's financial statements. Stoneridge Investment Partners, a Charter shareholder, brought a putative Rule 10b-5 class action against the suppliers alleging they participated in a deceptive scheme that enabled Charter's misstatements. The district court dismissed for failure adequately to plead reliance, and the Eighth Circuit affirmed. The Supreme Court granted certiorari.
Can private investors assert a Section 10(b)/Rule 10b-5 claim against secondary actors (such as a public company's vendors) based on their participation in a deceptive scheme where the actors did not make public statements or owe a duty to investors, and where investors did not rely on the actors' own conduct?
To state a private claim under Section 10(b) and Rule 10b-5, a plaintiff must allege: (1) a material misrepresentation or omission, or a manipulative or deceptive act by the defendant; (2) scienter; (3) a connection with the purchase or sale of a security; (4) reliance (transaction causation), which can be satisfied by direct reliance or, in the case of public statements, by the fraud-on-the-market presumption; (5) economic loss; and (6) loss causation. Reliance requires that the plaintiff relied on the defendant's own public misstatement, omission where there is a duty to disclose, or other deceptive conduct that was communicated to the market and attributable to the defendant. Private actions do not extend to aiding and abetting; only primary violators are liable in private suits under §10(b), while the SEC retains authority to pursue aiding-and-abetting under 15 U.S.C. §78t(e).
No. Because the suppliers' alleged deceptive acts were not disclosed to the investing public and were not attributed to them, investors could not have relied on those acts. The suppliers were, at most, aiders and abettors of Charter's misstatements and therefore are not subject to private Rule 10b-5 liability. The Eighth Circuit's dismissal was affirmed.
The Court, in an opinion by Justice Kennedy, emphasized reliance as an essential element in private Rule 10b-5 actions. Reliance links the defendant's deceptive conduct to the plaintiff's injury by assuring that the misrepresentation or deceptive act played a role in the plaintiff's decision to engage in the transaction. Under Basic's fraud-on-the-market doctrine, reliance may be presumed for public misstatements because those statements are incorporated into the market price. But where the defendant's conduct is undisclosed and not attributed to the defendant, there is no market reliance on that actor's behavior. The suppliers engaged in transactions with Charter that allegedly lacked a legitimate business purpose and were designed to facilitate Charter's accounting fraud. Nevertheless, investors were unaware of the suppliers' conduct; they relied only on Charter's financial statements. Extending reliance to every undisclosed, antecedent act in a causal chain would collapse the line between primary liability and aiding and abetting, contrary to Central Bank of Denver, which bars private aiding-and-abetting claims. The Court rejected the "scheme liability" theory advanced under Rule 10b-5(a) and (c) to the extent it would circumvent the reliance requirement by treating any participation in a deceptive plan as actionable by private plaintiffs. The Court also invoked policy considerations: the private right of action under §10(b) is a judicial creation warranting restraint. Expanding liability to customers and suppliers based on undisclosed conduct would expose a wide circle of actors—vendors, banks, accountants, lawyers—to unpredictable, potentially ruinous litigation, chilling legitimate business activity. Congress, through the PSLRA and §20(e), struck a balance by authorizing the SEC (but not private plaintiffs) to pursue aiding-and-abetting claims; it declined to expand private rights after Central Bank, signaling that any such extension is for Congress, not the courts. The majority concluded that because the suppliers' conduct was not communicated to the market and not attributable to them, the reliance element could not be met. Justice Stevens dissented, arguing that the suppliers' deceptive conduct was sufficiently direct and foreseeable to satisfy reliance and proximate cause, but the majority remained unpersuaded.
Stoneridge sharply limits private Rule 10b-5 liability against secondary actors. It confirms that private plaintiffs must show reliance on the defendant's own public misstatement or deceptive conduct that reached the market and was attributable to that defendant. Allegations that a secondary actor participated in a behind-the-scenes scheme enabling an issuer's fraud do not suffice. The decision preserves Central Bank's boundary between primary liability and aiding and abetting, reserves aiding-and-abetting enforcement to the SEC, and curbs expansive scheme-liability theories that would expose vendors and other business partners to open-ended securities-fraud risk. For law students, Stoneridge is essential to understanding the elements of a §10(b) claim—especially reliance—the scope of implied private rights, and the interaction between judicial doctrine and congressional policy choices in securities regulation.
Scheme liability refers to imposing Rule 10b-5 liability based on participation in a deceptive plan or course of conduct (often asserted under subsections (a) and (c)), even if the defendant did not make a public misstatement. The Court held that private plaintiffs cannot use scheme liability to evade the reliance requirement and Central Bank's bar on aiding-and-abetting liability. Because the suppliers' conduct was not disclosed to the market or attributed to them, investors could not have relied on it.
Stoneridge centers on reliance. The Court held that reliance requires a connection between the plaintiff's decision to trade and the defendant's own public statement or deceptive conduct reaching the market. The fraud-on-the-market presumption from Basic applies only when the defendant's public misstatement affects market price. Undisclosed conduct by a secondary actor does not meet this requirement.
No. Stoneridge limits private liability but leaves room for enforcement by the SEC, which Congress authorized to bring aiding-and-abetting actions under Exchange Act §20(e). Secondary actors may also face primary liability if they themselves make public misstatements or engage in deceptive conduct that is communicated to the market and attributed to them. They also remain subject to other legal regimes (e.g., criminal fraud, state law claims where not preempted).
Central Bank held that private plaintiffs cannot sue aiders and abettors under §10(b). Stoneridge applies and reinforces that principle by rejecting attempts to repackage aiding-and-abetting as scheme liability where the necessary reliance on the defendant's conduct is missing. The Court emphasized that expanding private liability beyond Central Bank is a legislative, not judicial, choice.
It made private Rule 10b-5 claims against secondary actors significantly harder to sustain unless the plaintiff can attribute a public misstatement or market-communicated deceptive act to the secondary actor. As a result, many claims targeting vendors, customers, banks, or professionals for behind-the-scenes roles in an issuer's fraud have been dismissed at the pleading stage for failure to allege reliance attributable to the defendant.
Stoneridge anchors private Rule 10b-5 liability in the reliance requirement and draws a clear boundary between primary violators and aiders and abettors. By insisting that a plaintiff's reliance be on the defendant's own publicly attributed conduct, the Court curtailed expansive theories that would have exposed a wide network of corporate counterparties to securities-fraud suits based on undisclosed transactions.
For students and practitioners, the case is a blueprint for analyzing §10(b) claims: identify the defendant's own deceptive act or statement, determine whether it reached the market, and assess whether reliance can be established (directly or via the fraud-on-the-market presumption). Absent those showings, private plaintiffs must look to other avenues—such as SEC enforcement or state-law remedies—rather than stretching the implied federal cause of action.
Need to cite this case?
Generate a perfectly formatted Bluebook citation in seconds.
Use our Bluebook Citation Generator →